Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alida Biosciences
San Diego, California, United Statesalidabio.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Alida Biosciences has launched commercial kits and software for multiplexed detection of RNA modifications. Their technology enables sensitive and accurate epitranscriptomic analysis from limited clinical samples. The company’s tools are used in basic research and translational applications to identify new drug targets and biomarkers but does not have its own therapeutic programs or clinical results[1][6].
- Therapeutic areas
- Other
- Modalities
- RNA analysis tools (not direct therapeutics)Epigenetic and epitranscriptomic profiling technologies
- Industry
- Drug Discovery Services
02
Partnerships
DNAnexus Inc. (for enhanced cloud-based genomics data analysis)[6]
Beyond the preview
Go deeper on Alida Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alida Biosciences.